These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 27215400

  • 1. Comparison of next generation sequencing, SNaPshot assay and real-time polymerase chain reaction for lung adenocarcinoma EGFR mutation assessment.
    Cernomaz AT, Macovei II, Pavel I, Grigoriu C, Marinca M, Baty F, Peter S, Zonda R, Brutsche M, Grigoriu B.
    BMC Pulm Med; 2016 May 23; 16(1):88. PubMed ID: 27215400
    [Abstract] [Full Text] [Related]

  • 2. Comparison of targeted next-generation sequencing with conventional sequencing for predicting the responsiveness to epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) therapy in never-smokers with lung adenocarcinoma.
    Han JY, Kim SH, Lee YS, Lee SY, Hwang JA, Kim JY, Yoon SJ, Lee GK.
    Lung Cancer; 2014 Aug 23; 85(2):161-7. PubMed ID: 24857785
    [Abstract] [Full Text] [Related]

  • 3. Comparison of epidermal growth factor receptor mutation detection turnaround times and concordance among real-time polymerase chain reaction, high-throughput next-generation sequencing and the Biocartis Idylla™ platforms in non-small cell lung carcinomas.
    Sharma S, Satapathy A, Aggarwal A, Dewan A, Jain E, Katara R, Kumar V, Pal R, Pandey S, Naidu MM, Kini L, Pradhan D, Mohanty SK.
    Pathol Res Pract; 2021 Apr 23; 220():153394. PubMed ID: 33706124
    [Abstract] [Full Text] [Related]

  • 4. Frequently used quantitative polymerase chain reaction-based methods overlook potential clinically relevant genetic alterations in epidermal growth factor receptor compared with next-generation sequencing: a retrospective clinical comparison of 1839 lung adenocarcinomas.
    Tønnesen E, Lade-Keller J, Stougaard M.
    Hum Pathol; 2021 Sep 23; 115():67-75. PubMed ID: 34153308
    [Abstract] [Full Text] [Related]

  • 5. Detection and comparison of peptide nucleic acid-mediated real-time polymerase chain reaction clamping and direct gene sequencing for epidermal growth factor receptor mutations in patients with non-small cell lung cancer.
    Kim HJ, Lee KY, Kim YC, Kim KS, Lee SY, Jang TW, Lee MK, Shin KC, Lee GH, Lee JC, Lee JE, Kim SY.
    Lung Cancer; 2012 Mar 23; 75(3):321-5. PubMed ID: 21930325
    [Abstract] [Full Text] [Related]

  • 6. Comparison of Next-Generation Sequencing, Quantitative PCR, and Sanger Sequencing for Mutation Profiling of EGFR, KRAS, PIK3CA and BRAF in Clinical Lung Tumors.
    Gao J, Wu H, Shi X, Huo Z, Zhang J, Liang Z.
    Clin Lab; 2016 Mar 23; 62(4):689-96. PubMed ID: 27215089
    [Abstract] [Full Text] [Related]

  • 7. Comparison of targeted next-generation sequencing (NGS) and real-time PCR in the detection of EGFR, KRAS, and BRAF mutations on formalin-fixed, paraffin-embedded tumor material of non-small cell lung carcinoma-superiority of NGS.
    Tuononen K, Mäki-Nevala S, Sarhadi VK, Wirtanen A, Rönty M, Salmenkivi K, Andrews JM, Telaranta-Keerie AI, Hannula S, Lagström S, Ellonen P, Knuuttila A, Knuutila S.
    Genes Chromosomes Cancer; 2013 May 23; 52(5):503-11. PubMed ID: 23362162
    [Abstract] [Full Text] [Related]

  • 8. The Advantage of Targeted Next-Generation Sequencing over qPCR in Testing for Druggable EGFR Variants in Non-Small-Cell Lung Cancer.
    Szpechcinski A, Moes-Sosnowska J, Skronska P, Lechowicz U, Pelc M, Szolkowska M, Rudzinski P, Wojda E, Maszkowska-Kopij K, Langfort R, Orlowski T, Sliwinski P, Polaczek M, Chorostowska-Wynimko J.
    Int J Mol Sci; 2024 Jul 19; 25(14):. PubMed ID: 39063150
    [Abstract] [Full Text] [Related]

  • 9. Detection of Epidermal Growth Factor Receptor Mutations in Lung Adenocarcinoma: Comparing Cobas 4800 EGFR Assay With Sanger Bidirectional Sequencing.
    Ardakani NM, Giardina T, Grieu-Iacopetta F, Tesfai Y, Carrello A, Taylor J, Robinson C, Spagnolo D, Amanuel B.
    Clin Lung Cancer; 2016 Sep 19; 17(5):e113-e119. PubMed ID: 26961433
    [Abstract] [Full Text] [Related]

  • 10. Picoliter-Droplet Digital Polymerase Chain Reaction-Based Analysis of Cell-Free Plasma DNA to Assess EGFR Mutations in Lung Adenocarcinoma That Confer Resistance to Tyrosine-Kinase Inhibitors.
    Seki Y, Fujiwara Y, Kohno T, Takai E, Sunami K, Goto Y, Horinouchi H, Kanda S, Nokihara H, Watanabe S, Ichikawa H, Yamamoto N, Kuwano K, Ohe Y.
    Oncologist; 2016 Feb 19; 21(2):156-64. PubMed ID: 26768482
    [Abstract] [Full Text] [Related]

  • 11. Effective assessment of egfr mutation status in bronchoalveolar lavage and pleural fluids by next-generation sequencing.
    Buttitta F, Felicioni L, Del Grammastro M, Filice G, Di Lorito A, Malatesta S, Viola P, Centi I, D'Antuono T, Zappacosta R, Rosini S, Cuccurullo F, Marchetti A.
    Clin Cancer Res; 2013 Feb 01; 19(3):691-8. PubMed ID: 23243218
    [Abstract] [Full Text] [Related]

  • 12. Monitoring of somatic mutations in circulating cell-free DNA by digital PCR and next-generation sequencing during afatinib treatment in patients with lung adenocarcinoma positive for EGFR activating mutations.
    Iwama E, Sakai K, Azuma K, Harada T, Harada D, Nosaki K, Hotta K, Ohyanagi F, Kurata T, Fukuhara T, Akamatsu H, Goto K, Shimose T, Kishimoto J, Nakanishi Y, Nishio K, Okamoto I.
    Ann Oncol; 2017 Jan 01; 28(1):136-141. PubMed ID: 28177428
    [Abstract] [Full Text] [Related]

  • 13. Next-Generation Sequencing for Genotyping of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Samples in Lung Cancer.
    Xie F, Zheng X, Mao X, Zhao R, Ye J, Zhang Y, Sun J.
    Ann Thorac Surg; 2019 Jul 01; 108(1):219-226. PubMed ID: 30885850
    [Abstract] [Full Text] [Related]

  • 14. Comparison of EGFR mutation detection between the tissue and cytology using direct sequencing, pyrosequencing and peptide nucleic acid clamping in lung adenocarcinoma: Korean multicentre study.
    Min KW, Kim WS, Jang SJ, Choi YD, Chang S, Jung SH, Kim L, Roh MS, Lee CS, Shim JW, Kim MJ, Lee GK, Korean Cardiopulmonary Pathology Study Group.
    QJM; 2016 Mar 01; 109(3):167-73. PubMed ID: 26031706
    [Abstract] [Full Text] [Related]

  • 15. A novel, rapid point-of-care test for lung cancer patients to detect epidermal growth factor receptor gene mutations by using real-time droplet-PCR and fresh liquid cytology specimens.
    Asaka S, Yoshizawa A, Matsuda K, Yamaguchi A, Yamamoto H, Shiina T, Nakata R, Ogawa K, Zhang M, Honda T.
    Oncol Rep; 2017 Feb 01; 37(2):1020-1026. PubMed ID: 27922678
    [Abstract] [Full Text] [Related]

  • 16. Impact of tissue type and content of neoplastic cells of samples on the quality of epidermal growth factor receptor mutation analysis among patients with lung adenocarcinoma.
    Paliogiannis P, Attene F, Cossu A, Defraia E, Porcu G, Carta A, Sotgiu MI, Pazzola A, Cordero L, Capelli F, Fadda GM, Ortu S, Sotgiu G, Palomba G, Sini MC, Palmieri G, Colombino M.
    Mol Med Rep; 2015 Jul 01; 12(1):187-91. PubMed ID: 25683726
    [Abstract] [Full Text] [Related]

  • 17. FNA smears as a potential source of DNA for targeted next-generation sequencing of lung adenocarcinomas.
    Treece AL, Montgomery ND, Patel NM, Civalier CJ, Dodd LG, Gulley ML, Booker JK, Weck KE.
    Cancer Cytopathol; 2016 Jun 01; 124(6):406-14. PubMed ID: 26882436
    [Abstract] [Full Text] [Related]

  • 18. Clinical outcomes of EGFR-TKI treatment and genetic heterogeneity in lung adenocarcinoma patients with EGFR mutations on exons 19 and 21.
    Yu JY, Yu SF, Wang SH, Bai H, Zhao J, An TT, Duan JC, Wang J.
    Chin J Cancer; 2016 Mar 21; 35():30. PubMed ID: 27001083
    [Abstract] [Full Text] [Related]

  • 19. Microfluidics-based EGFR mutation detection and its implication in the resource-limited clinical setting.
    Joshi P, Gogte P, Pai T, Gurav M, Dhanawade D, Karnik N, Deshpande G, Kaushal R, Shetty O.
    Int J Exp Pathol; 2024 Jun 21; 105(3):90-99. PubMed ID: 38717047
    [Abstract] [Full Text] [Related]

  • 20. Clinical characteristics and treatment outcomes of lung adenocarcinomas with discrepant EGFR mutation testing results derived from PCR-direct sequencing and real-time PCR-based assays.
    Chiu CH, Ho HL, Chiang CL, Lin SF, Ma HH, Chuang YT, Lin KY, Tsai CM, Chou TY.
    J Thorac Oncol; 2014 Jan 21; 9(1):91-6. PubMed ID: 24346097
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.